Topical beta-blockers are not associated with an increased risk of treatment for depression.

Abstract

PURPOSE:

To investigate the effect of topical beta-blockers on the prevalence of depression among glaucoma patients.

DESIGN:

Retrospective observational population-based cohort study.

PARTICIPANTS:

We reviewed the electronic medical records of all the members in a district of the largest health maintenance organization in Israel (Central District of Clalit Health Services) who were older than 20 years (317,469 members).

METHODS:

We documented all antiglaucoma prescriptions (n = 274,023) and all antidepressant prescriptions (n = 16,948) filled by glaucoma patients in the district between January 1, 2001 and December 31, 2003. We included only those patients who filled at least 6 consecutive antiglaucoma prescriptions at least once every 2 months (n = 6597; 5846 [88.6%] were treated with topical beta-blockers). Depressed patients were defined as patients that filled at least four prescriptions for antidepressants during the study period (n= 810, 12.3% of all glaucoma patients).

MAIN OUTCOME MEASURE:

Relationship of topical beta-blocker use and prevalence of depression among glaucoma patients.

RESULTS:

No significant demographic differences were noted between glaucoma patients treated and not treated with topical beta-blockers. Of those treated and not treated with beta-blockers, 12.2% (12.7% after age-adjustment) and 12.7%, respectively, were also receiving drug therapy for depression (P = 0.7, chi-square test). With stratification by age, treatment with topical beta-blockers did not influence the prevalence of depression in any age group. Logistic regression analysis revealed a significant effect of age, place of birth, and gender on the prevalence of depression, but the prevalence of use of topical beta-blockers had no significant effect.

CONCLUSIONS:

Use of topical beta-blockers by glaucoma patients does not appear to increase the risk of depression in this population.

• Authors: Igor Kaiserman, Nadia Kaiserman, Asher Elhayany, Shlomo Vinker
• Journal: Ophthalmology (Ophthalmology) Vol. 113 Issue 7 Pg. 1077-80 (Jul 2006) ISSN: 1549-4713 [Electronic] United States
• PMID: 16815397 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Adrenergic beta-Antagonists
• Antidepressive Agents
• Antihypertensive Agents

Topics

• Administration, Topical
• Adrenergic beta-Antagonists (therapeutic use)
• Aged
• Aged, 80 and over
• Antidepressive Agents (therapeutic use)
• Antihypertensive Agents (therapeutic use)
• Chronic Disease
• Depression (drug therapy, epidemiology)
• Drug Prescriptions (statistics & numerical data)
• Female
• Glaucoma, Open-Angle (drug therapy)
• Health Maintenance Organizations (statistics & numerical data)
• Humans
• Israel (epidemiology)
• Male
• Middle Aged
• Prevalence
• Retrospective Studies
• Risk Factors